gadolinium labeled fibrin-binding peptide (EPIX Medical)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug Namegadolinium labeled fibrin-binding peptide (EPIX Medical)
Drug Alias NameEP-2104R
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEpixDyax Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEpixDyax Corp
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A